Cardiac stimulating apparatus and method for heart failure therapy

• US 5,334,222 A
• Filed: 11/03/1992
• Issued: 08/02/1994
• Est. Priority Date: 11/03/1992
• Status: Expired due to Term

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Spinelli, Julio C., Tockman, Bruce A., Salo, Rodney W.
• Primary Examiner(s): Kamm, William E.
• Assistant Examiner(s): Getzow, Scott
• Application Number:
  US07/970,893
• Time in Patent Office: 637 Days
• Field of Search: 128/419 PG
• US Class Current: 607/17
• CPC Class Codes: A61N 1/3622 comprising two or more electrodes co-operating with different heart regions
• CPC Class Codes: A61N 1/3627 for treating a mechanical deficiency of the heart, e.g. congestive heart failure or cardiomyopathy
• CPC Class Codes: A61N 1/3682 with a variable atrioventricular delay
• CPC Class Codes: A61N 1/39622 Pacing therapy

Abstract

A cardiac rhythm management device includes a dual-chamber pacemaker especially designed for treating congestive heart failure and a defibrillator as a back-up measure. The device incorporates a programmed microcontroller which is operative to adjust the AV delay of the pacemaker to a minimum or maximum length consistent with optimal cardiac function. The cardiac stimulator includes apparatus for sensing cardiac function from cycle-to-cycle and determining whether incremental changes made to the AV delay interval enhances or worsens the measured cardiac function. On each iterative cycle, the AV delay interval is changed, either incremented or decremented, until a cross-over point is reached in which it is noted that the cardiac function ceases to improve and this is followed with a further incremental adjustment in an opposite direction to compensate for any overshoot. By providing a cardiac defibrillator in combination with the pacing device with closed-loop control of the AV interval, incidences of sudden death due to lethal arrhythmias is reduced.

Claims

1. A method of operating an implantable cardiac stimulator implanted in a patient suffering from congestive heart failure, said cardiac stimulator being of the type having means for sensing atrial activity, means for sensing ventricular activity, means for sensing cardiac function of the heart, means for stimulating at least one ventricular chamber, and microprogrammable controller means coupled to said means for sensing said atrial activity, said means for sensing ventricular activity and said means for sensing cardiac function, said microprogrammable controller means controlling said means for stimulating said at least one ventricular chamber so as to issue ventricular stimulating pulses at computed AV delay intervals following the sensing of an atrial event, comprising the steps of:

(a) computing the electromechanical interval (EMI) of the patient'"'"'s heart using information derived from said cardiac function sensing means, said atrial sensing means and said ventricular sensing means;

(b) computing the atrial cycle length (ACL) of the patient'"'"'s heart using information derived from said atrial sensing means;

(c) changing the AV delay parameter of said pacemaker by a known increment from a previous value when it is determined that EMI is less than ACL;

(d) using said cardiac function sensing means to determine whether each of the incremental changes in the AV delay parameter enhanced the cardiac function of the patient'"'"'s heart measured on a previous cycle;

(e) repeating steps (a)-(d) until it is determined in step (d) that cardiac function degraded; and

(f) adjusting the AV interval by a pre-programmed small time value.

2. The method as in claim 1 wherein said step of computing the EMI of the patient'"'"'s heart includes the steps of:

(a) determining from said cardiac function sensing means the pre-ejection period (PEP), the ejection time (ET) and the early filling time (EFT) of the patient'"'"'s heart; and

(b) computing the sum of AV delay, PEP, ET and EFT.

3. The method as in claim 1 wherein said step of computing EMI of the patient'"'"'s heart comprises:

(a) using said cardiac function sensing means to determine the Active Time (AT) of the patient'"'"'s heart.

4. The method as in claim 3 wherein AT is determined by the steps of:

(a) measuring the time variations of intracardiac impedance of the patient'"'"'s heart due to influx and outflow of blood from one cardiac chamber;

(b) deriving from the measured time variation of intracardiac impedance, the maximum filling rate following end-systole; and

(c) measuring the time interval between the start of a cardiac contraction and the end of the filling phase of the ventricles with the ventricles being filled at their maximum filling rate.

5. The method as in claim 1 wherein said means for sensing cardiac function comprises intracardiac impedance sensing means disposed within said dual-chamber pacemaker and operative to measure at least one of maximum rate of change of impedance, stroke volume, and cardiac output.

6. The method as in claim 1 wherein said dual chamber pacemaker includes a means for detecting heart sounds and the method for computing EMI comprises the steps of:

(a) sensing said atrial activity using said atrial sensing means;

(b) sensing the rapid filling phase of the cardiac cycle using said means for detecting heart sounds; and

(c) determining the time elapsing between the sensing of atrial activity and the end of the rapid filling phase.

7. The method as in claim 1 and further including the step of applying a cardioverting shock to the heart upon detection of an inordinately high heart rate.

8. A totally implantable cardiac pacemaker for treating congestive heart failure comprising, in combination:

(a) means for periodically measuring the EMI of the patient'"'"'s heart;

(b) means for periodically measuring the ACL of the patient'"'"'s heart;

(c) means for producing a cardiac tissue stimulating pulse upon the extraction of a computed AV interval following the occurrence of an atrial event;

(d) means coupled to said EMI measuring means and said ACL measuring means for periodically comparing the magnitude of said EMI and said ACL on repetitive cycles and for changing an existing AV interval by a predetermined time increment when EMI is less than ACL;

(e) means for measuring a predetermined cardiac function of the heart during each of said repetitive cycles and comparing said cardiac function to that existing prior to the time that said AV interval had been changed; and

(f) means for decreasing said AV interval by a predetermined amount only when the comparison of the two cardiac functions on successive cycles shows a decrease in said cardiac function in the latter of said successive cycles.

9. The cardiac pacemaker as in claim 8 and further including means for detecting lethal arrhythmias;

and

means responsive to said detecting means for delivering a cardioverting shock to said patient'"'"'s heart.

10. The cardiac pacemaker as in claim 8 and further including:

(a) means operative when ACL is determined to be smaller than EMI for initially setting the AV interval such that ACL and EMI become equal.

11. The cardiac pacemaker as in claim 8 wherein said means for measuring the EMI of the patient'"'"'s heart includes:

(a) intracardiac impedance sensing means; and

(b) means coupled to said impedance sensing means for determining the heart'"'"'s Active Time.

12. The cardiac pacemaker as in claim 8 wherein said means for measuring the EMI of the patient'"'"'s heart comprises:

(a) heart sound detecting means for detecting acoustic signals generated by heart mechanical activity; and

(b) means coupled to said heart sound detecting means and said means for sensing atrial activity for determining the interval between an atrial depolarization and the end of the heart'"'"'s fast filling phase.

13. The cardiac pacemaker as in claim 8 wherein said means for measuring a cardiac function comprises:

(a) means for measuring any one of stroke volume, cardiac output, maximum rate of change of intracardiac impedance, right ventricular end systolic pressure, right ventricular pulse pressure, peak rate of change of ventricular volume, peak rate of change of ventricular pressure, peak aortic flow of velocity, peak pulmonic flow or velocity, integrated aortic flow or velocity integrated pulmonic flow or velocity, heart sounds or any analog of any of these parameters.